Last updated 2026-06-18
- Acquired by Stryker Corporation, Oct 2013
- Raised $5M funding round, Jan 2010
- Raised $5M funding round, Nov 2007
Total raised
$10.0M
Last: 2010-01
Stage
Acquired
Founded
2006
Headcount
6
HQ
Haifa, Israel
Sector
—
About
ActiViews, a medical device company, develops, manufactures and markets surgical navigation solutions.
Funding history · 2 rounds · $10.0M total
2010-01
2007-11
Q&A
- What is ActiViews' primary business?
- ActiViews is a medical device company that develops, manufactures, and markets surgical navigation solutions, specifically a CT-guided Lung Biopsy Device.
- When was ActiViews founded?
- ActiViews was founded in January 2006.
- What is the total amount of funding ActiViews has raised?
- ActiViews has raised a total of $10,000,000 USD.
- When was ActiViews' last funding round and who were the investors?
- ActiViews' last funding round was in January 2010. Investors included 7 Health Ventures and Ofer Hi-Tech.
- Who acquired ActiViews and when?
- ActiViews was acquired by Stryker Corporation in October 2013.
- Where is ActiViews headquartered?
- ActiViews is headquartered in Haifa, North District, Israel.
- Who are the co-founders of ActiViews?
- The co-founders of ActiViews are Pinchas Gilboa and Yuval Zuk.
Team · 2
Sectors & technology
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
videosoftware-applicationsdiagnosticspulmonarybiopharmaceuticalhospitalssurgical-instrumentsct-scanmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| facebook.com/ActiViews-168939713171897 |
Identifiers & details
| Founded | 2006-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Acquired (Inactive) by Stryker Corporation on Oct 2013 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Stryker Corporation 2013-10
Radar intelligence
Patents
| EPO | 5 |
|---|